AXQ Capital’s Globus Medical GMED Stock Holding History

AXQ Capital’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,247	Closed	-$371K	–	1100
2025 Q4	$371K	Buy	+4,247	New	+$322K	0.08%	365
2024 Q2	–	Sell	-29,203	Closed	-$1.57M	–	555
2024 Q1	$1.57M	Buy	29,203 +13,903	+91%	+$747K	0.38%	64
2023 Q4	$815K	Buy	+15,300	New	+$746K	0.22%	163

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AXQ Capital's GMED Position: Q1 2026 in Review

AXQ Capital sold out of Globus Medical (GMED) in Q1 2026, closing a stake of 4,247 shares — an estimated $371K sold.

AXQ Capital first reported a position in GMED in Q4 2023 and held it in 3 quarters. The position peaked at $1.57M in Q1 2024. 610 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

AXQ Capital reported no remaining Globus Medical position as of Q1 2026 after selling out during the quarter.
AXQ Capital sold 4,247 Globus Medical shares in Q1 2026, an estimated $371K.
AXQ Capital first reported a position in Globus Medical in Q4 2023 and held it in 3 quarters.
AXQ Capital's Globus Medical position peaked at $1.57M in Q1 2024.
610 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.